Aseptic Neutrophilic Meningitis With Hypoglycorrhachia Following a Single Ocrelizumab Infusion

Affiliations

¹ From the Brigham Multiple Sclerosis Center (S.C., E.R., K.C., T.S.), Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Sturdy Memorial Hospital (H.N., R.P., R.D., T.S.), Attleboro, MA; and Division of Infectious Disease (T.B.E.), Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
² From the Brigham Multiple Sclerosis Center (S.C., E.R., K.C., T.S.), Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Sturdy Memorial Hospital (H.N., R.P., R.D., T.S.), Attleboro, MA; and Division of Infectious Disease (T.B.E.), Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. tsinghal@bwh.harvard.edu.

Case Reports

Steven Cicero et al. Neurol Neuroimmunol Neuroinflamm. 2021.

. 2021 Jul 1;8(5):e1025.

doi: 10.1212/NXI.0000000000001025. Print 2021 Sep.

¹ From the Brigham Multiple Sclerosis Center (S.C., E.R., K.C., T.S.), Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Sturdy Memorial Hospital (H.N., R.P., R.D., T.S.), Attleboro, MA; and Division of Infectious Disease (T.B.E.), Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
² From the Brigham Multiple Sclerosis Center (S.C., E.R., K.C., T.S.), Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Sturdy Memorial Hospital (H.N., R.P., R.D., T.S.), Attleboro, MA; and Division of Infectious Disease (T.B.E.), Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. tsinghal@bwh.harvard.edu.

No abstract available

References

1. Myhr KM, Torkildsen O, Lossius A, Bo L, Holmoy T. B cell depletion in the treatment of multiple sclerosis. Expert Opin Biol Ther. 2019;19(3):261-271. - PubMed
1. Moris G, Garcia-Monco JC. The challenge of drug-induced aseptic meningitis. Arch Intern Med. 1999;159(11):1185-1194. - PubMed
1. Moris G, Garcia-Monco JC. The challenge of drug-induced aseptic meningitis revisited. JAMA Intern Med. 2014;174(9):1511-1512. - PubMed
1. Redman RCt, Miller JB, Hood M, DeMaio J. Trimethoprim-induced aseptic meningitis in an adolescent male. Pediatrics. 2002;110(pt 2):e26. - PubMed
1. Gibiansky E, Petry C, Mercier F, et al. . Ocrelizumab in relapsing and primary progressive multiple sclerosis: pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIO. Br J Clin Pharmacol. 2021;87(6):2511-2520. - PMC - PubMed